You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Submit to Antibodies Review for Antibodies

Journal Menu

Journal Browser

► Journal Browser

Most Cited & Viewed

Most Cited & Viewed Papers

Most Cited Papers
Most Viewed Papers
Most Downloaded Papers

Citations	Article
41	Introduction to Antibody-Drug Conjugates by Mark C. Pettinato
28	Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer by Violet Y. Tu, Asma Ayari and Roddy S. O’Connor
19	Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies by Brian A. Baldo
15	A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19) by Kristin Widyasari and Jinnam Kim
15	Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS by Emmanuel J. Favaloro, Leonardo Pasalic and Giuseppe Lippi
14	Alternative Routes of Administration for Therapeutic Antibodies—State of the Art by Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
14	Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications by Guanjie Li, Hiroyuki Suzuki, Teizo Asano, Tomohiro Tanaka, Hiroyoshi Suzuki, Mika K. Kaneko and Yukinari Kato
13	From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry by Darja Kanduc
13	Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants by Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
12	Allergen-Specific IgE and IgG4 as Biomarkers for Immunologic Changes during Subcutaneous Allergen Immunotherapy by Georgi Nikolov, Yana Todordova, Radoslava Emilova, Diana Hristova, Maria Nikolova and Bogdan Petrunov

Citations	Article
15	A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19) by Kristin Widyasari and Jinnam Kim
14	Alternative Routes of Administration for Therapeutic Antibodies—State of the Art by Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
14	Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications by Guanjie Li, Hiroyuki Suzuki, Teizo Asano, Tomohiro Tanaka, Hiroyoshi Suzuki, Mika K. Kaneko and Yukinari Kato
13	Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants by Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
10	*Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico* Investigation by Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry and Suprabhat Mukherjee**
10	Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions by Thomas Böldicke
9	IgY Antibodies as Biotherapeutics in Biomedicine by Diana León-Núñez, María Fernanda Vizcaíno-López, Magdalena Escorcia, Dolores Correa, Elizabeth Pérez-Hernández and Fernando Gómez-Chávez
9	FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying Hypothesis by Margaret A. Lindorfer and Ronald P. Taylor
8	Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect by Toshihiko Tashima
8	A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG_2a-f) Exerts Antitumor Activity in Xenograft Model by Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K. Kaneko and Yukinari Kato

Citations	Article
5	Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier by Toshihiko Tashima
4	Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy by Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
4	The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease by Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
3	Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody by Jun Fang, Shifa Lai, Haoyang Yu and Lan Ma
3	Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy by Chi Hun Song, Minchan Jeong, Hyukmin In, Ji Hoe Kim, Chih-Wei Lin and Kyung Ho Han
3	IgA Nephropathy: Current Treatment and New Insights by Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
2	Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease by Meshal Alshamrani
2	Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease by Weronika Grąźlewska and Lucyna Holec-Gąsior
2	Recent Progress in Antibody Epitope Prediction by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
2	Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes by Daniel Chiu, John Rhee and L. Nicolas Gonzalez Castro

Citations	Article
2	Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis by Dimitrina Miteva, Georgi V. Vasilev and Tsvetelina Velikova
1	Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies by Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
1	Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy by Karsten Beckmann, Carmen Reitinger, Xianglei Yan, Anna Carle, Eva Blümle, Nicole Jurkschat, Claudia Paulmann, Sandra Prassl, Linda V. Kazandjian, Karin Loré, Falk Nimmerjahn and Stephan Fischer
1	Immune Responses to Anti-Hepatitis C Virus Antibodies during Pre-Liver Transplantation Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Recipients Associated with Post-Liver Transplantation Allograft Injury by Shu-Hsien Lin, Kun-Ta Wu, Chih-Chi Wang, Kuang-Tzu Huang, Li-Wen Hsu, Hock-Liew Eng and King-Wah Chiu
1	Prediction of Antibody Viscosity from Dilute Solution Measurements by Kamal Bhandari, Yangjie Wei, Brendan R. Amer, Emma M. Pelegri-O’Day, Joon Huh and Jeremy D. Schmit
1	Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature by Maxime Taghavi, Abla Jabrane, Lucas Jacobs, Maria Do Carmo Filomena Mesquita, Anne Demulder and Joëlle Nortier
1	Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein by Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilli Show full author list Hide full author list
1	Neutralization of Different Variants of SARS-CoV-2 by a F(ab′)2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding Domain by Mariajosé Rodriguez-Nuñez, Mariana del Valle Cepeda, Carlos Bello, Miguel Angel Lopez, Yoneira Sulbaran, Carmen Luisa Loureiro, Ferdinando Liprandi, Rossana Celeste Jaspe, Flor Helene Pujol and Héctor Rafael Rangel

Citations	Article
361	Monoclonal Antibodies in Cancer Therapy by David Zahavi and Louis Weiner
268	Antibody Structure and Function: The Basis for Engineering Therapeutics by Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov and Gary L. Gilliland
149	Design and Production of Bispecific Antibodies by Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland and Michael J. Betenbaugh
134	David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments by Adam Bates and Christine A. Power
123	IgA: Structure, Function, and Developability by Patrícia de Sousa-Pereira and Jenny M. Woof
109	Autoantibodies in SLE: Specificities, Isotypes and Receptors by Barbara Dema and Nicolas Charles
108	Developments and Challenges for mAb-Based Therapeutics by Sumit Goswami, Wei Wang, Tsutomu Arakawa and Satoshi Ohtake
107	The Ligands for Human IgG and Their Effector Functions by Steven W. de Taeye, Theo Rispens and Gestur Vidarsson
106	Structure, Function, and Therapeutic Use of IgM Antibodies by Bruce A. Keyt, Ramesh Baliga, Angus M. Sinclair, Stephen F. Carroll and Marvin S. Peterson
105	Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment by Rena Liu, Robert J. Oldham, Emma Teal, Stephen A. Beers and Mark S. Cragg

More Articles...

Views	Article
10352	Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies by Brian A. Baldo
9414	Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective by Andrew T. Lucas, Amber Moody, Allison N. Schorzman and William C. Zamboni
8585	New Opportunities in Glycan Engineering for Therapeutic Proteins by Xiaotian Zhong, Aaron M. D’Antona, John J. Scarcelli and Jason C. Rouse
8518	Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics by Taihei Murakami, Shigefumi Kumachi, Yasuhiro Matsunaga, Miwa Sato, Kanako Wakabayashi-Nakao, Hidekazu Masaki, Ryo Yonehara, Maiko Motohashi, Naoto Nemoto and Masayuki Tsuchiya
8392	Persistent Hyper IgA as a Marker of Immune Deficiency: A Case Report by Russell J. Hopp and Hana B. Niebur
8065	Introduction to Antibody-Drug Conjugates by Mark C. Pettinato
7771	Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors by Shasha Li, Alex J. McCraw, Richard A. Gardner, Daniel I.R. Spencer, Sophia N. Karagiannis and Gerd K. Wagner
7764	*IgG Avidity Test as a Tool for Discrimination between Recent and Distant Toxoplasma gondii* Infection—Current Status of Studies by Lucyna Holec-Gąsior and Karolina Sołowińska**
7711	Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers by Uwe Reusch, Kristina Ellwanger, Ivica Fucek, Thomas Müller, Ute Schniegler-Mattox, Joachim Koch and Michael Tesar
7056	A New Method to Characterize Conformation-Specific Antibody by a Combination of Agarose Native Gel Electrophoresis and Contact Blotting by Teruo Akuta, Toshiaki Maruyama, Chiaki Sakuma, Masataka Nakagawa, Yui Tomioka, Kevin Entzminger, Jonathan K. Fleming, Ryo Sato, Takashi Shibata, Yasunori Kurosawa, C. J. Okumura and Tsutomu Arakawa

Views	Article
7764	*IgG Avidity Test as a Tool for Discrimination between Recent and Distant Toxoplasma gondii* Infection—Current Status of Studies by Lucyna Holec-Gąsior and Karolina Sołowińska**
6876	Alternative Routes of Administration for Therapeutic Antibodies—State of the Art by Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
6377	Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology by Gertrudis Rojas
6263	New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond by Marino Paroli, Chiara Gioia and Daniele Accapezzato
6046	Elevated IgE Levels—An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections? by Polina Kostova, Vera Papochieva, Dimitrinka Miteva, Bilyana Georgieva, Sirma Mileva, Martin Shahid, Tsvetelin Lukanov and Guergana Petrova
6018	Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants by Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
5537	Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy by Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
5412	IgA Nephropathy: Current Treatment and New Insights by Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
5083	Recent Progress in Antibody Epitope Prediction by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
5081	Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein by Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilli Show full author list Hide full author list

Views	Article
6046	Elevated IgE Levels—An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections? by Polina Kostova, Vera Papochieva, Dimitrinka Miteva, Bilyana Georgieva, Sirma Mileva, Martin Shahid, Tsvetelin Lukanov and Guergana Petrova
5537	Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy by Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
5412	IgA Nephropathy: Current Treatment and New Insights by Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
5083	Recent Progress in Antibody Epitope Prediction by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
5081	Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein by Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilli Show full author list Hide full author list
5039	Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier by Toshihiko Tashima
4920	Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease by Weronika Grąźlewska and Lucyna Holec-Gąsior
4320	From Cereal Grains to Immunochemistry—What Role Have Antibodies Played in the History of the Home Pregnancy Test by Kinga Lis
4101	The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease by Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
4028	Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes by Daniel Chiu, John Rhee and L. Nicolas Gonzalez Castro

Views	Article
5081	Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein by Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilli Show full author list Hide full author list
3425	Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies by Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
2805	Heterogeneity in Disulfide Bond Reduction in IgG1 Antibodies Is Governed by Solvent Accessibility of the Cysteines by Ramakrishnan Natesan, Andrew B. Dykstra, Akash Banerjee and Neeraj J. Agrawal
2709	Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis by Dimitrina Miteva, Georgi V. Vasilev and Tsvetelina Velikova
2695	Prediction of Antibody Viscosity from Dilute Solution Measurements by Kamal Bhandari, Yangjie Wei, Brendan R. Amer, Emma M. Pelegri-O’Day, Joon Huh and Jeremy D. Schmit
2593	An Engineered Mouse Model That Generates a Diverse Repertoire of Endogenous, High-Affinity Common Light Chain Antibodies by Yinghui Rong, I-Ling Chen, Lance Larrabee, Manali S. Sawant, Germaine Fuh and Patrick Koenig
2366	Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
2352	A Novel Anti-CD47 Nanobody Tetramer for Cancer Therapy by Nataliya M. Ratnikova, Yulia Kravchenko, Anna Ivanova, Vladislav Zhuchkov, Elena Frolova and Stepan Chumakov
2235	Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies by Sarah Julien, Inès Challier, Marine Malleter, Fabienne Jouen, Laurent Drouot and Olivier Boyer
2209	Rapid Generation of Murine Bispecific Antibodies Using FAST-Ig^TM for Preclinical Screening of HER2/CD3 T-Cell Engagers by Hikaru Koga, Haruka Kuroi, Rena Hirano, Hiroyuki Hirayama, Yoshiaki Nabuchi and Taichi Kuramochi

Views	Article
71000	Antibody Structure and Function: The Basis for Engineering Therapeutics by Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov and Gary L. Gilliland
35672	In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments by Philippe P. Monnier, Robin J. Vigouroux and Nardos G. Tassew
35046	Monoclonal Antibodies in Cancer Therapy by David Zahavi and Louis Weiner
34442	Antibody Glycosylation and Inflammation by Kai-Ting C. Shade and Robert M. Anthony
34293	Antibody Aggregation: Insights from Sequence and Structure by Wei Li, Ponraj Prabakaran, Weizao Chen, Zhongyu Zhu, Yang Feng and Dimiter S. Dimitrov
32940	Design and Production of Bispecific Antibodies by Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland and Michael J. Betenbaugh
31953	Antibody Fragments and Their Purification by Protein L Affinity Chromatography by Gustav Rodrigo, Mats Gruvegård and James M. Van Alstine
29633	Antibody Drug Conjugates as Cancer Therapeutics by Pamela A. Trail
28357	IgG Antibody 3D Structures and Dynamics by Jacob White Jay, Brinkley Bray, Yaozhi Qi, Eseosaserea Igbinigie, Hao Wu, Jinping Li and Gang Ren
28227	Developments and Challenges for mAb-Based Therapeutics by Sumit Goswami, Wei Wang, Tsutomu Arakawa and Satoshi Ohtake

More Articles...

Downloads	Article
4359	Introduction to Antibody-Drug Conjugates by Mark C. Pettinato
2958	Alternative Routes of Administration for Therapeutic Antibodies—State of the Art by Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
2592	A New Method to Characterize Conformation-Specific Antibody by a Combination of Agarose Native Gel Electrophoresis and Contact Blotting by Teruo Akuta, Toshiaki Maruyama, Chiaki Sakuma, Masataka Nakagawa, Yui Tomioka, Kevin Entzminger, Jonathan K. Fleming, Ryo Sato, Takashi Shibata, Yasunori Kurosawa, C. J. Okumura and Tsutomu Arakawa
2560	Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer by Violet Y. Tu, Asma Ayari and Roddy S. O’Connor
2536	Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies by Brian A. Baldo
2454	The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use by Rita Tavarozzi and Enrica Manzato
2327	Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants by Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
2236	Persistent Hyper IgA as a Marker of Immune Deficiency: A Case Report by Russell J. Hopp and Hana B. Niebur
2134	Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers by Uwe Reusch, Kristina Ellwanger, Ivica Fucek, Thomas Müller, Ute Schniegler-Mattox, Joachim Koch and Michael Tesar
2112	Effect of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Antibody–Drug Conjugates (ADCs) by Iftekhar Mahmood

Downloads	Article
2958	Alternative Routes of Administration for Therapeutic Antibodies—State of the Art by Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
2327	Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants by Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
1926	A Simple Method for the Prediction of Human Concentration–Time Profiles and Pharmacokinetics of Antibody–Drug Conjugates (ADC) from Rats or Monkeys by Iftekhar Mahmood
1768	Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions by Thomas Böldicke
1650	Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect by Toshihiko Tashima
1641	Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier by Toshihiko Tashima
1604	IgA Nephropathy: Current Treatment and New Insights by Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
1544	Antibody-Based Approaches to Target Pancreatic Tumours by Marie Sorbara, Pierre Cordelier and Nicolas Bery
1430	On the Rapid Calculation of Binding Affinities for Antigen and Antibody Design and Affinity Maturation Simulations by Simone Conti, Edmond Y. Lau and Victor Ovchinnikov
1367	New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond by Marino Paroli, Chiara Gioia and Daniele Accapezzato

Downloads	Article
1641	Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier by Toshihiko Tashima
1604	IgA Nephropathy: Current Treatment and New Insights by Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
1090	Recent Progress in Antibody Epitope Prediction by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
1078	The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease by Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
1008	Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies by Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
879	Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy by Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
832	Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines by Monica L. Fernández-Quintero, Nancy D. Pomarici, Anna-Lena M. Fischer, Valentin J. Hoerschinger, Katharina B. Kroell, Jakob R. Riccabona, Anna S. Kamenik, Johannes R. Loeffler, James A. Ferguson, Hailee R. Perrett, Klaus R. Liedl, Julianna Han and Andrew B. Ward
811	Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy by Chi Hun Song, Minchan Jeong, Hyukmin In, Ji Hoe Kim, Chih-Wei Lin and Kyung Ho Han
798	Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants by Robert Pejchal, Anthony B. Cooper, Michael E. Brown, Maximiliano Vásquez and Eric M. Krauland
798	The Role of Antibody-Based Therapies in Neuro-Oncology by Rishab Ramapriyan, Jing Sun, Annabel Curry, Leland G. Richardson, Tarun Ramesh, Matthew A. Gaffey, Patrick C. Gedeon, Elizabeth R. Gerstner, William T. Curry and Bryan D. Choi

Downloads	Article
1008	Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies by Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
621	Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
572	Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis by Dimitrina Miteva, Georgi V. Vasilev and Tsvetelina Velikova
517	Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry and Higher-Energy Collisional Dissociation-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation and Ultraviolet Photodissociation by Eleanor Watts, Aarti Bashyal, Sean D. Dunham, Christopher M. Crittenden and Jennifer S. Brodbelt
481	Rapid Generation of Murine Bispecific Antibodies Using FAST-Ig^TM for Preclinical Screening of HER2/CD3 T-Cell Engagers by Hikaru Koga, Haruka Kuroi, Rena Hirano, Hiroyuki Hirayama, Yoshiaki Nabuchi and Taichi Kuramochi
478	Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy by Karsten Beckmann, Carmen Reitinger, Xianglei Yan, Anna Carle, Eva Blümle, Nicole Jurkschat, Claudia Paulmann, Sandra Prassl, Linda V. Kazandjian, Karin Loré, Falk Nimmerjahn and Stephan Fischer
462	Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein by Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilli Show full author list Hide full author list
457	Heterogeneity in Disulfide Bond Reduction in IgG1 Antibodies Is Governed by Solvent Accessibility of the Cysteines by Ramakrishnan Natesan, Andrew B. Dykstra, Akash Banerjee and Neeraj J. Agrawal
457	A Novel Anti-CD47 Nanobody Tetramer for Cancer Therapy by Nataliya M. Ratnikova, Yulia Kravchenko, Anna Ivanova, Vladislav Zhuchkov, Elena Frolova and Stepan Chumakov
439	Navigating the Challenges of Gluten Enteropathy and Infertility: The Role of Celiac-Related Antibodies and Dietary Changes by Monika Peshevska-Sekulovska, Milena Gulinac, Radoslav Rangelov, Desislava Docheva, Tsvetelina Velikova and Metodija Sekulovski

Downloads	Article
30543	Developments and Challenges for mAb-Based Therapeutics by Sumit Goswami, Wei Wang, Tsutomu Arakawa and Satoshi Ohtake
26272	Design and Production of Bispecific Antibodies by Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland and Michael J. Betenbaugh
24519	Antibody Fragments and Their Purification by Protein L Affinity Chromatography by Gustav Rodrigo, Mats Gruvegård and James M. Van Alstine
20487	Antibody Drug Conjugates as Cancer Therapeutics by Pamela A. Trail
17361	Antibody Structure and Function: The Basis for Engineering Therapeutics by Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov and Gary L. Gilliland
13975	Monoclonal Antibodies in Cancer Therapy by David Zahavi and Louis Weiner
13772	Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity by Kathleen P. Pratt
13591	Antibody Glycosylation and Inflammation by Kai-Ting C. Shade and Robert M. Anthony
13388	David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments by Adam Bates and Christine A. Power
13292	A Review of Deep Learning Methods for Antibodies by Jordan Graves, Jacob Byerly, Eduardo Priego, Naren Makkapati, S. Vince Parish, Brenda Medellin and Monica Berrondo

Back to TopTop